Patrick J. Jermain - Nov 13, 2024 Form 4 Insider Report for PLEXUS CORP (PLXS)

Signature
/s/ Patrick J. Jermain, by Kate A. Gitter, Attorney-in-Fact
Stock symbol
PLXS
Transactions as of
Nov 13, 2024
Transactions value $
-$296,951
Form type
4
Date filed
11/15/2024, 04:55 PM
Previous filing
Nov 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLXS Common Stock, $.01 par value Options Exercise +4.05K +18.45% 26K Nov 13, 2024 Direct F2
transaction PLXS Common Stock, $.01 par value Tax liability -$297K -1.91K -7.32% $155.88 24.1K Nov 13, 2024 Direct
holding PLXS Common Stock, $.01 par value 3.59K Nov 13, 2024 401(k) F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLXS Performance Stock Units Award +632 +9.97% 6.97K Nov 13, 2024 Common Stock, $.01 par value 632 Direct F2
transaction PLXS Performance Stock Units Options Exercise -4.05K -58.12% 2.92K Nov 13, 2024 Common Stock, $.01 par value 4.05K Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Plexus Corp. common stock held in the Plexus Corp. 401(k) Retirement Plan as of the last report from the Plan's trustee.
F2 Based on Company performance during the three-year performance period, 118.5% of the portion of the Performance Stock Units ("PSUs") granted in fiscal 2022 related to economic return goals vested. The three-year performance period for the portion of the PSUs that vests based on the relative total shareholder return ("TSR") of the Company's common stock as compared to companies in the S&P 400 Index has yet to conclude. As previously disclosed, the reporting person had the opportunity to earn up to 200% of the targeted amount based on ER originally reported and has the opportunity to earn up to 150% of the targeted amount based on TSR originally reported.